ArticleCureus2026
Association of COVID-19 Infection and SARS-CoV-2 Vaccination With Echocardiographic Pericardial Involvement in a Real-World Outpatient Cohort.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background During the COVID‑19 pandemic, inflammatory myopericardial syndromes have been reported following SARS‑CoV‑2 infection and SARS‑CoV‑2 vaccination. However, the prevalence of such conditions in routine clinical practice, including mild or residual pericardial alterations, remains incompletely characterized. This study aimed to evaluate the association between prior SARS-CoV-2 infection, SARS-CoV-2 vaccination, and echocardiographic pericardial involvement in a real-world outpatient cohort undergoing routine transthoracic echocardiography. Methods This retrospective cohort study analyzed 1,431 consecutive patients undergoing routine outpatient echocardiography from 2018 to 2022 at the Istituto di Medicina Biologica di Milano, Milan, Italy. Pericardial involvement was defined as echocardiographic findings consistent with pericardial inflammation, including pericardial effusion, thickening, hyperechogenicity, and fibrinous strands, encompassing not only clinically evident pericarditis but also minimal pericardial alterations and residual findings. Multivariable logistic regression and average marginal effects were used to assess associations with prior COVID‑19 infection, SARS‑CoV‑2 vaccination status, age, sex, and BMI, adjusting for calendar year and confounders. Results Pre‑pandemic pericardial involvement was detected in 101/459 (22%) examinations (2018-2019), rising to 463/673 (68.8%) during the pandemic years (2020-2022; P < 0.001). Both prior COVID‑19 infection (odds ratio (OR) 1.99, 95% confidence interval (CI) 1.17-3.43, P = 0.012) and vaccination (OR 2.08, 95% CI 1.29-3.35, P = 0.003) were independently associated with pericardial involvement, with a significant interaction suggesting that prior infection attenuated additional risk from vaccination, and vice versa. Female sex, older age, and higher BMI were also associated with higher odds. Conclusions In this real-world echocardiography cohort, both SARS-CoV-2 infection and vaccination were associated with increased odds of echocardiographic pericardial involvement, including minimal and residual alterations. The marked temporal rise during the pandemic may reflect a combination of subclinical inflammatory changes and evolving referral and diagnostic practices, while the absolute risk of vaccine-associated myopericarditis remained low compared with the overall benefits of vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.